623 related articles for article (PubMed ID: 17015227)
1. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
Hauser SL; Oksenberg JR
Neuron; 2006 Oct; 52(1):61-76. PubMed ID: 17015227
[TBL] [Abstract][Full Text] [Related]
2. The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis.
Inglese M; Benedetti B; Filippi M
J Neurol Sci; 2005 Jun; 233(1-2):15-9. PubMed ID: 15949493
[TBL] [Abstract][Full Text] [Related]
3. Neurodegeneration in autoimmune CNS inflammation.
Herz J; Zipp F; Siffrin V
Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
[TBL] [Abstract][Full Text] [Related]
4. [Neuronal injury in multiple sclerosis].
Correale J; Meli F; Ysrraelit C
Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
[TBL] [Abstract][Full Text] [Related]
5. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
Recks MS; Bader J; Kaiser CC; Schroeter M; Fink GR; Addicks K; Kuerten S
Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis: is there neurodegeneration independent from inflammation?
Lassmann H
J Neurol Sci; 2007 Aug; 259(1-2):3-6. PubMed ID: 17367814
[TBL] [Abstract][Full Text] [Related]
7. Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
Aktas O; Waiczies S; Zipp F
J Neuroimmunol; 2007 Mar; 184(1-2):17-26. PubMed ID: 17222462
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
Minagar A; Toledo EG; Alexander JS; Kelley RE
J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and degeneration in multiple sclerosis.
Brück W; Stadelmann C
Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.
Van der Walt A; Butzkueven H; Kolbe S; Marriott M; Alexandrou E; Gresle M; Egan G; Kilpatrick T
Pharmacol Ther; 2010 Apr; 126(1):82-93. PubMed ID: 20122960
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
Charil A; Filippi M
J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis of neurodegeneration in multiple sclerosis.
Lassmann H; van Horssen J
FEBS Lett; 2011 Dec; 585(23):3715-23. PubMed ID: 21854776
[TBL] [Abstract][Full Text] [Related]
13. Macrophages and neurodegeneration.
Hendriks JJ; Teunissen CE; de Vries HE; Dijkstra CD
Brain Res Brain Res Rev; 2005 Apr; 48(2):185-95. PubMed ID: 15850657
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis: a battle between destruction and repair.
McQualter JL; Bernard CC
J Neurochem; 2007 Jan; 100(2):295-306. PubMed ID: 17101032
[TBL] [Abstract][Full Text] [Related]
15. Neurodegeneration and -protection in autoimmune CNS inflammation.
Diem R; Sättler MB; Bähr M
J Neuroimmunol; 2007 Mar; 184(1-2):27-36. PubMed ID: 17188756
[TBL] [Abstract][Full Text] [Related]
16. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
17. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
[TBL] [Abstract][Full Text] [Related]
18. [A critical review of the current pathogenesis of multiple sclerosis and possible future trends].
Casanova B; Burgal M; Coret F
Rev Neurol; 1999 May 1-15; 28(9):909-15. PubMed ID: 10390758
[TBL] [Abstract][Full Text] [Related]
19. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.
Oksenberg JR; Baranzini SE; Sawcer S; Hauser SL
Nat Rev Genet; 2008 Jul; 9(7):516-26. PubMed ID: 18542080
[TBL] [Abstract][Full Text] [Related]
20. Novel therapeutic targets for axonal degeneration in multiple sclerosis.
Petratos S; Azari MF; Ozturk E; Papadopoulos R; Bernard CC
J Neuropathol Exp Neurol; 2010 Apr; 69(4):323-34. PubMed ID: 20448478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
